BABA / Company research

Alibaba earnings and filings

Financial results, original SEC reports and source-linked quarterly highlights.

SEC EDGAR / Collected

Reports and results announcements

FiledFormReport dateDocuments
20-F Mar 31, 2026 Annual reportAll exhibits and attachments
20-F Mar 31, 2025 Annual reportAll exhibits and attachments
20-F Mar 31, 2024 Annual reportAll exhibits and attachments
20-F/A Mar 31, 2023 Annual reportAll exhibits and attachments
20-F Mar 31, 2023 Annual reportAll exhibits and attachments
20-F Mar 31, 2022 Annual reportAll exhibits and attachments
20-F Mar 31, 2021 Annual reportAll exhibits and attachments
20-F Mar 31, 2020 Annual reportAll exhibits and attachments
20-F Mar 31, 2019 Annual reportAll exhibits and attachments
20-F Mar 31, 2018 Annual reportAll exhibits and attachments
20-F Mar 31, 2017 Annual reportAll exhibits and attachments
20-F Mar 31, 2016 Annual reportAll exhibits and attachments
20-F Mar 31, 2015 Annual reportAll exhibits and attachments

An 8-K marked Item 2.02 announces results; the earnings release or presentation may be an exhibit under “All exhibits and attachments.” Filings are official source documents, not an audit performed by this publication.

BABA annual investment, R&D and cash flow

Quarterly highlights and original SEC reports

Verified annual USD facts from SEC filings. Collected .

Annual period Revenue Cash capex Productive asset purchases Operating cash flow Free cash flow R&D R&D / revenue
to $148.4 billion Not available Not available $11.05 billion Not available $9.65 billion 6.5%
Revenues · 20-F filed · accession 0001193125-26-231755
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0001193125-26-231755
ResearchAndDevelopmentExpense · 20-F filed · accession 0001193125-26-231755
to $137.3 billion Not available Not available $22.53 billion Not available $7.88 billion 5.7%
Revenues · 20-F filed · accession 0000950170-25-090161
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0000950170-25-090161
ResearchAndDevelopmentExpense · 20-F filed · accession 0000950170-25-090161
to $130.35 billion Not available Not available $25.29 billion Not available $7.24 billion 5.6%
Revenues · 20-F filed · accession 0000950170-24-063767
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0000950170-24-063767
ResearchAndDevelopmentExpense · 20-F filed · accession 0000950170-24-063767
to $126.49 billion Not available Not available $29.09 billion Not available $8.26 billion 6.5%
Revenues · 20-F filed · accession 0000950170-23-033752
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0000950170-23-033752
ResearchAndDevelopmentExpense · 20-F filed · accession 0000950170-23-033752
SEC filing data: definitions, coverage and revisions

Source: the SEC Company Facts API, using standard US GAAP facts in USD from annual 10-K, 20-F or 40-F filings and amendments. Periods must span 300-400 days. Quarterly and year-to-date values are not presented as annual totals.

  • Cash capex is cash payments to acquire property, plant and equipment. It excludes broader acquisition or intangible-asset tags and is not total AI spending or an estimate of finance-lease investment.
  • Productive asset purchases are a separately reported, broader cash investment measure. They are shown in their own column and never substituted into PP&E capex, capital intensity or free cash flow. Do not rank mixed definitions as if they were identical.
  • Free cash flow here is operating cash flow minus cash capex. It may differ from a company's adjusted free cash flow definition. If either input is missing, the result is omitted.
  • R&D intensity is reported research and development expense divided by revenue from the same annual reporting period. Operating cash margin and capital intensity use the same-period revenue denominator.
  • Figures are company-wide, not AI-specific or segment-level. Financial years differ, so compare the displayed start and end dates rather than assuming calendar-year alignment.
  • The latest available filing for each supported fact is used, including restated comparative figures. Conflicting values from equally recent reports are omitted. Every figure retains its XBRL tag, accession and filing date.

Company-specific extension tags, IFRS-only data and unsupported definitions are not estimated. Missing standard facts are shown as unavailable, not zero. Data is refreshed in the background; the collection time is separate from the filing date.

Source: SEC EDGAR. Company-specific segment metrics and unsupported accounting tags are not estimated.